World Vaccine Congress US 2025
July 21, 2025
Summary:
- Protective immunity depends not just on antibody titers, but also on Fc effector functions that engage the immune system through phagocytosis, cytotoxicity, and complement activation.
- Fc-mediated functions play a critical role in differentiating antibody quality, helping explain protection in the absence of high titers or neutralization.
- Comprehensive profiling across diverse immune cell types provides a more accurate understanding of efficacy and safety for both vaccine candidates and therapeutic antibodies.
- SeromYx’s high-throughput, antigen-specific assays and computational analytics offer powerful tools to identify correlates of protection and guide candidate selection.
Authors: Lenny Moise, PhD.
The World Vaccine Congress Europe 2025
Festival of Biologics
The Fc-Mediated Effector Function Summit
Authors: Kaplonek P, et al. Sci Transl Med. 2022 May 18;14(645):eabm2311.
Authors: Hawman, David W. et al. eBioMedicine, Volume 115, 105698
Authors: Crescioli, S, Jatiani, S, & Moise, L, (2025). mAbs, 17(1). Journal: mAbs
Authors: Osborn, G., López-Abente, J., Adams, R. et al.
Woburn, MA / Newark, DE – October 1st, 2024 - SeromYx Systems, a cutting-edge immunology technology company, and ACROBiosystems, a leading provider for life science solutions and tools, are excited to announce the release of their joint study on the...
Authors: P. Hsueh, M. Friedman, S. Jatiani (2024) Application Note
Authors: SeromYx Team (2024) White Paper
